• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Myrbetriq Sales

Quote

anonymous

Guest
Been out a while. Has Myrbetriq hit the number #1 prescribed OAB agent? Or Has the fact Vesicare is going generic stopped that? What about the fact a combo drug with those two will have crap coverage? How are the feeling of the sales force?
 








The OAB drugs are forced on to older patients who should not be receiving them due to the side effects. It is a tragic scene created and allowed by the medical and commercial franchise to ruin the elderly. Think about your grandparents abused by these drug peddlers. The drugs should be used very carefully but it is not the case.
 




The side effect of urinary retention leads to UTI. Why? It is known anytime you don’t empty the bladder on time chances of an infection are increased which may lead to complicated kidney infections and death because no one can bear the old people losing control. Old people are discarded and the poorly paid caretakers could care less. The treatment of old and frail in this country or anywhere in the world is mind boggling not to mention getting overloaded with drugs that they don’t need. One leak in 24 hours is considered OAB. Blasphemy. Think of the day you get old and have no control over what medications are put in your body. The old and the frail in LTC have no strength to fight it out and are being used only for money making. Visit your parents, grandparents, friends and relatives in Retirement homes and LTC and ask yourself if this is the drug you want to sell.
 




Top Bottom
Back
Quote